Starpharma Holdings Ltd (SPL) — Capital Reinvestment Ratio

Latest as of December 2025: 0.06x

Starpharma Holdings Ltd (SPL) has a Capital Reinvestment Ratio of 0.06x as of December 2025, meaning it reinvests 0% of its operating cash flow (AU$3.91 Million) in capital expenditures (AU$237.00K). Check tangible equity quality of Starpharma Holdings Ltd to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.06x
Capex / Operating Cash Flow

Operating Cash Flow

AU$3.91 Million
AUD

Capital Expenditures

AU$237.00K
AUD

Data as of

Dec 2025
Most recent filing

Annual Capital Reinvestment Ratio for Starpharma Holdings Ltd (None–None)

Year-by-year Capital Reinvestment Ratio for Starpharma Holdings Ltd from None to None. See Starpharma Holdings Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (AUD) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow